USANA Health Sciences has reported a decreased profit in the first quarter compared to the same period of the previous year, though it surpassed Wall Street's predictions. The company's income stood at $16.54 million, or $0.86 per share, in contrast to $18.38 million or $0.95 per share during last year's first quarter.
Thomson Reuters compiled data showing that analysts had anticipated the company's earnings to be around $0.69 per share on average, excluding any special items. The company's quarter revenue experienced a fall of 8.3%, dropping to $227.80 million from last year's $248.36 million.
To provide a snapshot of USANA Health Sciences' earning based on Generally Accepted Accounting Principles (GAAP), the figures are as follows:
Q1 Earnings: $16.54 million compared to last year's $18.38 million.
Q1 Earnings Per Share (EPS): $0.86 versus last year's $0.95.
Q1 Revenue: $227.80 million in contrast to last year's $248.36 million.
In terms of guidance for the full year, the projected EPS stands between $2.40 and $3.00. Meanwhile, the projected revenue range is anticipated to be between $850 million and $920 million.
